氧化低密度脂蛋白与高密度脂蛋白比值可预测轻型卒中或短暂性脑缺血发作患者的卒中复发
基于CHANCE试验3019例轻型缺血性卒中或高危短暂性脑缺血发作患者,测定基线氧化低密度脂蛋白(oxLDL)与高密度脂蛋白(HDL)水平。校正混杂因素后,oxLDL/HDL最高四分位组90天内卒中复发风险是最低四分位组的1.50倍(HR 1.50,95%CI 1.08-2.08,P=0.02),1年及联合血管事件等次要结局结果相似(P均<0.05)。oxLDL/HDL与是否使用他汀类药物无显著交互作用。
要点
- oxLDL/HDL最高四分位组90天内卒中复发风险是最低四分位组的1.50倍(HR 1.50,95%CI 1.08-2.08,P=0.02)。
- 1年卒中及90天和1年缺血性卒中、联合血管事件等次要结局结果与主要结局相似(P均<0.05)。
- oxLDL/HDL与使用他汀类药物之间无显著交互作用。
核心结论
- 轻型卒中或短暂性脑缺血发作患者血清oxLDL/HDL水平较高与90天和1年卒中复发风险增加相关。
- oxLDL/HDL可能作为轻型卒中或短暂性脑缺血发作患者卒中复发的有力指标。
研究设计与样本
- 研究纳入CHANCE试验(氯吡格雷用于高危急性非致残性脑血管事件患者)中3019例轻型缺血性卒中或高危短暂性脑缺血发作患者。
- 测定基线oxLDL和HDL水平,采用Cox比例风险模型分析oxLDL/HDL与卒中复发的关联。
主要发现
- 校正相关混杂因素后,oxLDL/HDL最高四分位组90天内卒中复发风险是最低四分位组的1.50倍(HR 1.50,95%CI 1.08-2.08,P=0.02)。
- 次要结局(1年内任何卒中、90天内和1年内缺血性卒中及联合血管事件)结果与主要结局相似(P均<0.05)。
- oxLDL/HDL与使用他汀类药物之间无显著交互作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Oxidized low-density lipoprotein (oxLDL) level is thought to be associated with recurrent stroke. We aimed to investigate the association between oxLDL to high-density lipoprotein (HDL) ratio and recurrent stroke in patients with minor stroke or transient ischemic attack. Methods- The study included 3019 patients with minor ischemic stroke or high-risk transient ischemic attack from the CHANCE trial (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events). Baseline oxLDL and HDL levels were measured. The primary outcome was any stroke within 90 days. The secondary outcomes included any stroke within 1 year and ischemic stroke and combined vascular events within 90 days and 1 year. The association between oxLDL/HDL and recurrent stroke was analyzed by using Cox proportional hazards. Results- Patients in the highest oxLDL/HDL quartile had a higher risk of recurrent stroke within 90 days (hazards ratio, 1.50; 95% CI, 1.08-2.08) compared with the lowest quartile after adjusting relevant confounding factors ( P=0.02). Similar results were found for secondary outcomes ( P<0.05 for all). There were no significant interaction between oxLDL/HDL and use of statins agents. Conclusions- Higher serum oxLDL/HDL level in minor stroke or transient ischemic attack was associated with increased risk of recurrent stroke in 90 days and 1 year. OxLDL/HDL may act as a powerful indicator of recurrent stroke in patients with minor stroke or transient ischemic attack. Clinical Trial Registration- URL: http://www.clinicaltrials.gov . Unique identifier: NCT00979589.
引用
- Wang A, Li S, Zhang N, et al. Oxidized Low-Density Lipoprotein to High-Density Lipoprotein Ratio Predicts Recurrent Stroke in Minor Stroke or Transient Ischemic Attack. Stroke. 2018. PMID: 30355199. doi:10.1161/STROKEAHA.118.022077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。